foxo4-dri senolytic animal model 2023 2024 Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis Targeting the FOXO4-p53 axis by
Targeting the FOXO4 p53 axis by retro inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline Naunyn Schmiedeberg's Archives of Pharmacology Springer Nature Link Senolytic therapeutics: An emerging treatment modality for osteoarthritis ScienceDirect The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment npj Aging Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway
Pay in 4 interest-free payments of $7.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7





